跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
diphtheria/tetanus/pertussis combined vaccine
首页
药物
diphtheria/tetanus/pertussis combined vaccine
diphtheria/tetanus/pertussis combined vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE
申请人: CHANGCHUN BCHT BIOTECHNOLOGY CO
优先权: 2022
CN
EP
US
WO
4 件公开
Preparation method for absorbed acellular diphtheria, tetanus and pertussis combined vaccine
申请人: CHENGDU KANGHUA BIOLOG PROD CO
优先权: 2011
CN
Preparation method of pneumococcus-type b haemophilus influenzae-diphtheria-pertussis-tetanus combined vaccine
申请人: BRAVOVAX CO LTD
优先权: 2016
CN
IMMUNOGENIC COMPOSITION, DIPHTHERIA-TETANUS-PERTUSSIS COMBINED VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF
申请人: CANSINO BIOLOGICS INC
优先权: 2025
CN
WO
2 件公开
Preparation of domestic adsorhed diphtheria tetanus and acellular pertussis combined vaccine without formaldehyde and merthiolate
申请人: ZHEJIANG WEIXIN BIOLOG PHARMAC
优先权: 2008
CN
Combined vaccine for adsorbing Diphtheria, tetanus and acellular pertussis-Sabin inactivated poliovirus and preparation thereof
申请人: CHINESE ACAD MED SCIENCE
优先权: 2011
CN
Preparation method of adsorbed diphtheria, tetanus and acellular pertussis and hemophilus influenza type B tetravalent combined vaccine
申请人: CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD
优先权: 2017
CN
Separated and purified acellular pertussis-diphtheria-tetanus, b-type haemophilus influenzae and A-group and C-group meningococcus combined vaccine and preparation method thereof
申请人: OLYMVAX BIOPHARMACEUTICALS INC
优先权: 2015
CN
药物
反馈
